From: Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
Characteristics | Resected PDAC (Count = 96) | Un-resected PDAC (Count = 441) | Total (Count = 537) |
---|---|---|---|
N (%)/Mean (Std.) | N (%)/Mean (Std.) | N (%)/Mean (Std.) | |
Age (Years) | 61.17 (10.34)† | 66.32 (10.84) † | 65.40 (10.92) |
Sex (Male) | 54 (56.25) | 220 (49.89) | 274 (51.02) |
Chemotherapy (Yes) | 40 (41.67) | 185 (41.95) | 225 (41.90) |
Operation modality (Whipple) | 54 (56.25) | – | – |
Survival length (Days) | 497.92 (256.86)* | 306.10 (267.69)* | 340.39 (275.55) |
Baseline serum ALP (U/L) | 111.18 (109.15) § | 237.96 (283.90) § | 215.29 (265.78) |
Baseline serum ALB (g/L) | 34.11 (5.51) § | 37.16 (6.71) § | 36.62 (6.61) |
Baseline serum TBIL (μmol/L) | 49.89 (61.64) § | 44.44 (90.16) § | 45.41 (85.74) |
Baseline leukocyte count (109/L) | 12.99 (4.80) § | 7.30 (4.31) § | 8.32 (4.91) |